RTOG #89-06: A phase I study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in locally advanced malignancies

International Journal of Radiation Oncology, Biology, Physics

Volumn 28, Issue 1, 1994, Pages 201-206

  Halberg, Francine E ^a   Cosmatis, Dennis ^b   Gunderson, Leonard L ^c   Dirk Noyes, R ^d   Hanks, Gerald R ^e   Buswell, Laura ^f   Nagorney, David M ^b   Coleman, C Norman ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c MAYO CLINIC   (United States)

^d Latter Day Saints Hospital   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Enhancement; Etanidazole; Hypoxic cell; Intraoperative radiotherapy; Radiation sensitizer; SR 2508

Indexed keywords

ETANIDAZOLE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; FEMALE; HUMAN; MALE; METASTASIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOSENSITIZATION;

ADOLESCENT; ADULT; AGED; CELL HYPOXIA; COMBINED MODALITY THERAPY; ETANIDAZOLE; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS;

EID: 0028176906     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)90158-9     Document Type: Article

References (19)

1. Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel films
2. Possible role of potentiators in radiation therapy
3. Management of recurrent rectal cancer
4. Sample size and power determination for stratified clinical trials
5. Clinical trials of radiosensitizers: What should we expect?
6. The optimum time for irradiation relative to tumor concentration of hypoxic cell sensitizers
7. SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use
8. Current concepts in cancer care. Hypoxic sensitizers: implications for radiation therapy
9. SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use
10. Final report of the phase I trial of continuous infusion etanidazole (SR 2508): A radiation therapy oncology group study
11. A prospective study of treatment techniques to minimize the value of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation
12. Intraoperative irradiation for gastrointestinal cancers
13. Distribution of etanidazole into human brain tumors: Implications for treating high grade gliomas
14. Effective surgical adjuvant therapy for high-risk rectal carcinoma
15. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer
16. Clinical trials of hypoxic cell sensitizers
17. Surgical approaches and techniques in intraoperative radiotherapy for intra-abdominal, retroperitoneal and pelvic neoplasms
18. The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma
19. Treatment of locally advanced rectal cancer with external beam radiation, surgical resection, and intraoperative radiation therapy